BiVACOR, the medical device company supported by world-leading Griffith University research, has received a $20m funding boost in its quest to produce the world’s first total artificial heart (TAH).
The grant will support further clinical work on their TAH (which soon begins first-in-human trials) as well as development of a wireless power source for the device.
BiVACOR’s grant is part of a $50m Medical Research Futures Fund (MRFF) award to the Artificial Heart Frontiers Program, a research consortium that includes Griffith University’s GCHKP-based Mechanobiology Lab.
Led by Associate Professor Michael Simmonds, the lab supports of three life-changing cardiac devices supported by the MRFF grant: BiVACOR’s TAH, an implant to support a failing natural heart and a rapid-life support device.
Read the full story here and check out the video below on why BiVACOR chose the GCHKP!